Compass Pathways says depression drug has long-lasting benefits

Compass Pathways, a psychedelic biotech firm, is reporting long-lasting benefits from its psilocybin-based depression drug. This comes out of a STAT News report covering various biotech updates. The company is positioning this as a significant step for psychedelic-assisted therapy.